Buprenorphine: all 305 studies that test it

Page 1 of 4. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.

• Buprenorphine for the Management of Pain in Children With Sickle Cell DiseaseNot yet recruitingNCT07799571Phase 1
• BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP)RecruitingNCT07786012Phase 4
• Analgesia With Transdermal Buprenorphine Patch in Adults Undergoing Video-Assisted Thoracoscopic SurgeryRecruitingNCT07733128Not applicable
• A Bundled Intervention to End Opioid OverdosesRecruitingNCT07485335Phase 4
• Comparing Outpatient Treatment Retention Among Individuals Using Fentanyl Randomized to Low-dose and Direct-to-inject Buprenorphine InitiationNot yet recruitingNCT07469501Phase 4
• Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility TrialRecruitingNCT07439549Phase 4
• Examining Analgesic Synergy and Efficacy in Trauma CareNot yet recruitingNCT07435077Phase 4
• Comparison of the Efficacy and Safety of Intravenous Buprenorphine Administered Via PCA System Versus Oxycodone in the Management of Postoperative Pain After Video-Assisted Thoracoscopic SurgeryRecruitingNCT07434427Phase 4
• Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency DepartmentRecruitingNCT07430345Phase 1/2
• Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy ClinicRecruitingNCT07176351Phase 4
• Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture SurgeryRecruitingNCT06949826Phase 4
• Injectable Buprenorphine in Prison: A Preference TrialRecruitingNCT06880718Phase 4
• NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral SettingsNot yet recruitingNCT06854029Phase 4
• A Clinical Trial Comparing Buprenorphine Formulations for High Potency Synthetic Opioid UseRecruitingNCT06726200Early Phase 1
• Standard Versus High Dose ED-Initiated Buprenorphine InductionRecruitingNCT06494904Phase 3
• ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic PainRecruitingNCT06442566Phase 1/2
• Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl UseRecruitingNCT06379984Phase 2
• Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of OverdoseRecruitingNCT06316830Phase 2/3
• Low-dose Buccal Buprenorphine: Relative Abuse Potential and AnalgesiaRecruitingNCT05988710Phase 4
• Clinical Study on the Effect of Tizanidine on the Function and Pain of Patients After Shoulder ArthroscopyNot yet recruitingNCT05852093Early Phase 1
• Low-dose Buprenorphine as a Modulator of Social Motivation in SchizophreniaRecruitingNCT05778591Phase 2
• High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)RecruitingNCT05589181Phase 3
• Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use DisorderRecruitingNCT05011266Phase 2/3
• Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency DepartmentsRecruitingNCT04893525Phase 2/3
• A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderRecruitingNCT04375033Phase 4
• Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive EpisodeRecruitingNCT03646058Phase 3
• Houston Emergency Opioid Engagement SystemEnrolling by invitationNCT03396276Phase 4
• Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection LocationsCompletedNCT05704543Phase 4Results posted
• Monthly Injectable BUP for MA Use Disorder (MURB) TrialTerminatedNCT05283304Phase 2Results posted
• The Effect of Buprenorphine Continuation for Patients With Opioid Use DisorderTerminatedNCT04981678Phase 4Results posted
• Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer PatientsCompletedNCT04752384Phase 2Results posted
• Providing Suboxone and PrEP Using TelemedicineCompletedNCT04521920Not applicableResults posted
• Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1TerminatedNCT04480554Phase 2Results posted
• Brain Mechanisms of Pharmacotherapy in Opioid Use DisorderTerminatedNCT04454411Phase 2Results posted
• Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator InsertionCompletedNCT04254081Phase 4Results posted
• Opiate Suicide Study in Patients With Major DepressionCompletedNCT04116528Phase 3Results posted
• Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo.CompletedNCT03996694Phase 1Results posted
• Medication Treatment for Opioid Use Disorder in Expectant MothersCompletedNCT03918850Phase 3Results posted
• Rapid Initiation of Drug Treatment EngagementCompletedNCT03908437Phase 4Results posted
• Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSDTerminatedNCT03852628Phase 2Results posted
• Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent IndividualsTerminatedNCT03711318Phase 3Results posted
• Buprenorphine Pharmacometric Open Label Research Study of Drug ExposureCompletedNCT03608696Phase 1/2Results posted
• XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of ConceptCompletedNCT03604159Phase 4Results posted
• Assessing the Safety of Buprenorphine in People With Sickle Cell DiseaseCompletedNCT03492099Phase 2Results posted
• Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075CompletedNCT03248947Early Phase 1Results posted
• A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine RespondersCompletedNCT03232346Phase 3Results posted
• Buprenorphine as Adjunct to Outpatient Induction Onto VivitrolTerminatedNCT03113409Phase 2/3Results posted
• Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back PainCompletedNCT02946073Phase 3Results posted
• Open-Label Treatment Extension StudyCompletedNCT02896296Phase 3Results posted
• Neuroimaging Predictors of Relapse During Treatment for Opiate DependenceCompletedNCT02696096Phase 3Results posted
• Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use DisorderCompletedNCT02672111Phase 3Results posted
• Effects of Buprenorphine on Mood in Adults With a Range of Depressive SymptomatologyCompletedNCT02659787Not applicableResults posted
• Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid DependenceCompletedNCT02651584Phase 3Results posted
• Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe PainCompletedNCT02634788Phase 3Results posted
• Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate IntensityCompletedNCT02519387Phase 4Results posted
• Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use DisorderCompletedNCT02510014Phase 3Results posted
• Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of BuprenorphineCompletedNCT02357901Phase 3Results posted
• Buprenorphine/Naloxone Stabilization and Induction Onto Injection NaltrexoneCompletedNCT02294253Phase 2/3Results posted
• Prolonged Popliteal Fossa Nerve Blockade (Prolonged Pop)CompletedNCT02198235Phase 1Results posted
• Buprenorphine Treatment for Opioid DependenceCompletedNCT02187198Phase 3Results posted
• Buprenorphine Used With Treatment Resistant Depression in Older AdultsCompletedNCT02181231Phase 1/2Results posted
• A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal ImplantsCompletedNCT02180659Phase 3Results posted
• Incomplete Response in Late-Life Depression: Getting to Remission With BuprenorphineCompletedNCT02176291Phase 2Results posted
• Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid DisorderCompletedNCT02044094Phase 2Results posted
• Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent PopulationCompletedNCT02038790Phase 4Results posted
• The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy VolunteersCompletedNCT01999114Phase 1Results posted
• Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)CompletedNCT01983111Phase 4Results posted
• Prescription Opioid Abuse Among Pain Patients: Predictors of RelapseCompletedNCT01967641Phase 2Results posted
• Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle PainCompletedNCT01961271Phase 4Results posted
• Buprenorphine to Improve HIV Care Engagement and OutcomesCompletedNCT01936857Phase 4Results posted
• Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic PainTerminatedNCT01875848Phase 4Results posted
• Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal FilmCompletedNCT01871285Phase 2Results posted
• The Effects of Buprenorphine on Responses to Verbal TasksCompletedNCT01860287Early Phase 1Results posted
• Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired SubjectsCompletedNCT01846455Phase 4Results posted
• Dane County Drug Court Study for Addicted OffendersCompletedNCT01843751Phase 3Results posted
• Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain PatientsTerminatedNCT01841931Phase 4Results posted
• An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal DisordersCompletedNCT01818700Phase 4Results posted
• RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder.CompletedNCT01809106Phase 4Results posted
• Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent SubjectsCompletedNCT01738503Phase 2Results posted
• Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid DependenceCompletedNCT01690546Phase 2Results posted
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced SubjectsCompletedNCT01675167Phase 3Results posted
• Buprenorphine Disposition and CyclosporineCompletedNCT01648270Not applicableResults posted
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive SubjectsCompletedNCT01633944Phase 3Results posted
• Duration of Analgesic Effect for Ultrasound Guided Supraclavicular Blocks With the Addition of Buprenorphine to Local Anesthetic SolutionTerminatedNCT01583179Not applicableResults posted
• Buprenorphine Disposition and CYP3ACompletedNCT01576575Not applicableResults posted
• Fetal and Infant Effects of Maternal Buprenorphine TreatmentCompletedNCT01561079Phase 2/3Results posted
• Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain PatientsCompletedNCT01559454Phase 4Results posted
• HIV, Buprenorphine, and the Criminal Justice SystemCompletedNCT01550341Not applicableResults posted
• Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence SyndromeCompletedNCT01452789Phase 3Results posted
• Buprenorphine for Treatment Resistant DepressionCompletedNCT01407575Phase 3Results posted
• Cocaine Use Reduction With BuprenorphineCompletedNCT01402492Phase 2/3Results posted
• A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123)CompletedNCT01396005Phase 1Results posted
• Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in ChildrenCompletedNCT01324570Phase 3Results posted
• Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic PainCompletedNCT01298765Phase 3Results posted
• Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent IndividualsCompletedNCT01262092Phase 2Results posted
• Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and KetoconazoleCompletedNCT01259115Phase 1Results posted
• Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest PeriodsCompletedNCT01259102Phase 1Results posted
• Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back PainCompletedNCT01256450Phase 3Results posted
• Buprenorphine 8 mg Sublingual Tablets Under Fasting ConditionsCompletedNCT01157169Phase 1Results posted
• Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension StudyCompletedNCT01151098Phase 3Results posted

← Buprenorphine overview